Model No. | Nomenclature | Genotype |
---|---|---|
2334-F | B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)1100Mjb | ko/ko;tg/tg |
2334-M | B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)1100Mjb | ko/ko;tg/tg |
Model No. | Nomenclature | Genotype |
---|---|---|
2334-F | B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)1100Mjb | ko/ko;tg/tg |
2334-M | B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)1100Mjb | ko/ko;tg/tg |
Nomenclature: B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)1100Mjb
Origin
The OT-I microinjected model was developed by Dr. Francis Carbone of Monash Medical School and Dr. Michael Bevan of the University of Washington. The model was created by injecting the rearranged T cell receptor Valpha2-Jalpha26 (under the control of the alpha chain promoter and enhancer) and Vbeta5-Dbeta2-Jbeta2.6 (under the control of the MHC class I promoter and the Ig heavy chain enhancer) into B6 x B6.C-H2bm1 blastocysts. The resultant founders were then backcrossed to C57BL/6. Taconic received stock from Keio University in June 2001, and the mice were rederived by backcrossing to C57BL/6NTac. OT-I transgenic mice were crossed with a homozygous C57BL/6NTac Rag2 targeted mutation model (RAGN12-M), and intercrossed for homozygosity at the Rag2 allele. The model was rederived by embryo transfer and is maintained by mating of male and female mice homozygous for both the Rag2 disruption and the OT-I transgene.
Initial Publication:
Shinkai, Y, Rathbun, G, Lam, KP, Oltz, EM, Stewart, V, Mendelsohn, M, Charron, J, Datta, M, Young, F, Stall, AM, and Alt, FW. (1992) RAG-2-Deficient Mice Lack Mature Lymphocytes Owing to Inability to Initiate V(D)J Rearrangement, Cell, 68: 855-867.
Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
Need more info? Click the live chat button or Contact Us
Packing Practices
Taconic standard practice is to recombine animals of different home cages and/or ages from a single model and sex during packing, except in specific cases where Taconic's animal welfare policy prohibits recombination due to aggression or other concerns. When an order is fulfilled with animals from more than one week of birth, this standard practice results in animals from a range of birth weeks packed together in a single TTC. When an order is fulfilled with animals from genotyped models, this standard practice results in animals from different home cages packed together in a single TTC.
Customers who wish to keep animals from different weeks of birth separated should place orders with the special instruction "Divide and label by age." Note that this special request can result in increased costs for additional Taconic Transit Cages, dividers and/or freight charges.
Taconic discourages other types of custom packing requests as they can have a negative impact on animal welfare. Learn more.
Conditions of Use for Taconic Transgenic Models™
Taconic Transgenic Models™ (Models) are produced and distributed under rights to patents and intellectual property licensed from various institutions. Taconic sells the Models to purchasers, grants to each purchaser a right under Taconic's rights in such licensed patents and intellectual property to use the purchased Model in consideration of purchasers' acknowledgement of and agreement to the Terms and Conditions for Taconic Models, Products and Services and the following terms of use:
Age in Weeks | Quantity 1 - 999 |
3 to 10 | $407.00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | $407.00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | €347,00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | €347,00 |
Need help choosing the right Taconic Biosciences health standard for your research?
Use the Health Standard Selector to enter your exclusion list. The tool will tell you which health standards meet your requirements.
Speak with a PhD-level Field Application Scientist who can help you select the most appropriate model and maximize your experimental success.